Avoro Capital Advisors LLC
Annual return '25
+17.7%
SPY '25
+17.7%
Alpha
+0.0ptsvs SPY
Invested
$10.2B
Holdings
30
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 100%. 4 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$UTHR
UNITED THERAPEUTICS CORP
Q1 2026: Exited (was 2.61M shares)
15.4%
02
$ASND
ASCENDIS PHARMA
Q1 2026: Exited (was 100.0k shares)
11.4%
03
$MDGL
MADRIGAL PHARMACEUTICALS INC
Q1 2026: Exited (was 1.81M shares)
9.4%
04
$KRYS
KRYSTAL BIOTECH INC
Q1 2026: Exited (was 2.89M shares)
7.3%
05
$ARGX
ARGENX SE
Q1 2026: Exited (was 990.0k shares)
7.2%
06
$ARWR
ARROWHEAD PHARMACEUTICALS INC
Q1 2026: Exited (was 10.63M shares)
6.6%
07
$KYMR
KYMERA THERAPEUTICS INC
Q1 2026: Exited (was 7.47M shares)
6.1%
08
$APLS
APELLIS PHARMACEUTICALS INC
Q1 2026: Exited (was 12.22M shares)
4.8%
09
$CNTA
CENTESSA PHARMACEUTICALS PLC
Q1 2026: Exited (was 14.56M shares)
4.5%
10
$CELC
CELCUITY INC
Q1 2026: Exited (was 3.11M shares)
3.8%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Convergence · Pattern Engine ships in v1.1
30-day windowIn development
Convergence participation lands with the Pattern Engine.
Once the Pattern Engine ships, this section will list every active convergence event this fund is named in — with the other named funds, the Congress members on the same name, and combined position size.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 08:23 UTC.